期刊文献+

儿童急性上呼吸道感染并发血小板减少性紫癜的药学监护 被引量:3

Pharmaceutical Care on A Child Patient with Acute Upper Respiratory Infection and Immune Thrombocytopenic Purpura
下载PDF
导出
摘要 目的介绍临床药师参与1例儿童急性上呼吸道感染伴免疫性血小板减少性紫癜(ITP)的治疗并开展药学监护的经验和方法。方法临床药师对急性上呼吸道感染伴免疫性血小板减少性紫癜患儿协助医师治疗,优化药物治疗方案、提高患儿用药依从性、预防和处理药物可能不良反应的实施全程的药学监护。结果临床药师通过对患儿的药学监护,及时发现治疗问题并提供有效建议,达到满意的治疗效果。结论临床药师参与临床治疗实践,可协助医师制定药物治疗方案,保障临床合理安全用药。 Objective To summarize the experience of the clinical pharmacist involved in the treatment of acute upper respiratory tract infection combined with immune thrombocytopenic purpura (ITP) in a child patient, implicating the important role of the pharmacist in the therapeutic regimen management. Methods Through participating in the treatment of acute upper respiratory tract infection combined with childhood ITP, the clinical pharmacist took measures on optimizing the drug therapy, improvement of medication compliance for children, reasonable treatment on the possible adverse drug reactions and medication evaluation to implement pharmaceutical care. Results Clinical pharmacist provides pharmaceutical care and reasonable treatment advice during the whole therapeutic process.One acute upper respiratory tract infection child complicated with ITP was successfully cured. Conclusion Through participating in clinical practice, the clinical pharmacists can assist physicians in making a rational drug treatment plan and improving the safety of drug therapy.
作者 潘志星 雷臻珏 吴加勒 Zhixing PAN;Zhenjue LEI;Jiale WU(Department of Pharmacy,the People's Hospital Lishui City,Zhejiang Province,Lishui 323000,China)
出处 《医药导报》 CAS 北大核心 2018年第12期1527-1529,共3页 Herald of Medicine
关键词 感染 上呼吸道 急性 紫癜 血小板减少性/儿童 药学监护 Infection upper respiratory tract acute Purpura immune thrombocytopenic/Children Pharmaceutical care
  • 相关文献

参考文献4

二级参考文献104

  • 1李绪香.大剂量甲基强的松龙与静脉输注免疫球蛋白治疗急性血小板减少性紫癜临床观察[J].中国医药导报,2006,3(35):69-70. 被引量:3
  • 2奥野良信,万献尧,毕丽岩.金刚烷胺[J].日本医学介绍,2004,25(7):307-309. 被引量:20
  • 3顾岑.急性上呼吸道感染[M]//胡亚美,江载芳.诸福棠实用儿科学.7版.北京:人民卫生出版社,2002:1167-1170.
  • 4陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465.
  • 5Yong M, Schoonen WM, Li L, et al. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database. Br J Haematol, 2010, 149: 855-864.
  • 6Rosthcj S, Hedlund-Treutiger I, Rajantie J, et al. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children : A prospective nordic study of an unselected cohort. J Pediatr, 2003, 143:302-307.
  • 7Kiihne T, Buchanan GR, Zimmetlan S, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group. J Pediatr, 2003, 143 : 605 -608.
  • 8British Committee for Standards in Hematology General Hematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003. 120:574-596.
  • 9Geddis AE, Balduini CL. Diagnosis of immune thrombocytopenicpurpura in children. Curr Opin Hematol, 2007,14:520-525.
  • 10Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenie purpura of adults and children: report from an international working group. Blood, 2009, 113:2386-2393.

共引文献345

同被引文献37

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部